PANACEABIO

PANACEA BIOTEC

Small Cap BSE: 531349 NSE: PANACEABIO
₹142.65
1.95 (1.39%)
As on 08 December, 2022 | 09:01

Panacea Biotec Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in PANACEA BIOTEC

Start SIP

Panacea Biotec Share Price

Panacea Biotec Share Returns

  • Over 1 Month -0.38%
  • Over 3 Month 2.7%
  • Over 6 Month -4.65%
  • Over 1 Year -29.19%

Panacea Biotec Key Statistics

P/E Ratio 0.8
PEG Ratio 0
Market Cap Cr 874
Price to Book Ratio 1
EPS -15.3
Dividend 0
Relative Strength Index 55.88
Money Flow Index 54.53
MACD Signal -0.39
Average True Range 4.14

Panacea Biotec Investment Rating

  • Master Rating:
  • Panacea Biotec (Nse) has an operating revenue of Rs. 512.43 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 219% is great, ROE of 126% is exceptional. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 46 which is a POOR score indicating inconsistency in earnings, a RS Rating of 22 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 109 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Panacea Biotec Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 496142381193680
Operating Expenses Qtr Cr 5513361551375696
Operating Profit Qtr Cr -6-72-19-16-17-19-16
Depreciation Qtr Cr 6676667
Interest Qtr Cr 2212222
Tax Qtr Cr 0000002
Net Profit Qtr Cr -7-74-25-22-22-23-18

Panacea Biotec Technicals

EMA & SMA

Current Price
142.65
1.95 (1.39%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 140.11
  • 50 Day
  • 139.9
  • 100 Day
  • 141.78
  • 200 Day
  • 156.16
  • 20 Day
  • 139.23
  • 50 Day
  • 139.95
  • 100 Day
  • 137.53
  • 200 Day
  • 148.73

Panacea Biotec Resistance and Support

PIVOT
₹141.94
Resistance
First Resistance 143.77
Second Resistance 146.84
Third Resistance 148.67
RSI 55.88
MFI 54.53
MACD Single Line -0.39
MACD 0.15
Support
First Resistance 138.87
Second Resistance 137.04
Third Resistance 133.97

Panacea Biotec Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 58,306 3,560,164 61.06
Week 55,610 3,515,083 63.21
1 Month 43,550 2,613,854 60.02
6 Month 105,103 5,015,512 47.72

Panacea Biotec Result Highlights

Panacea Biotec Synopsis

NSE-Medical-Generic Drugs

Panacea Biotec L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 343.56 Cr. and Equity Capital is Rs. 6.13 Cr. for the Year ended 31/03/2021. Panacea Biotec Ltd. is a Public Limited Listed company incorporated on 02/02/1984 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L33117PB1984PLC022350 and registration number is 022350.
Market Cap 874
Sales 190
Shares in Float 1.59
No of funds 5
Yield
Book Value 2.22
U/D Vol ratio 1.7
LTDebt / Equity 20
Alpha -0.12
Beta 0.65

Panacea Biotec

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 73.59%73.59%73.59%
Mutual Funds
Foreign Portfolio Investors 0.14%
Individual Investors 15.79%15.6%15.14%
Others 10.48%10.81%11.27%

Panacea Biotec Management

Name Designation
Mr. Soshil Kumar Jain Chairman
Dr. Rajesh Jain Managing Director
Mr. Sandeep Jain Joint Managing Director
Mr. Ankesh Jain Whole Time Director
Mr. R L Narasimhan Non Executive Director
Mr. N N Khamitkar Non Executive Director
Mr. K M Lal Non Executive Director
Mrs. Manjula Upadhyay Non Executive Director
Mr. Bhupinder Singh Non Executive Director
Mr. Mukul Gupta Non Executive Director
Mr. Narotam Kumar Juneja Non Executive Director

Panacea Biotec Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Panacea Biotec Corporate Action

Date Purpose Remarks
2022-11-14 Quarterly Results
2022-08-09 Quarterly Results
2022-05-18 Audited Results
2022-02-14 Quarterly Results
2022-02-01 Others To consider Fund Raising

Panacea Biotec MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Panacea Biotec FAQs

What is Share Price of Panacea Biotec ?

Panacea Biotec share price is ₹142 As on 08 December, 2022 | 08:47

What is the Market Cap of Panacea Biotec ?

The Market Cap of Panacea Biotec is ₹873.7 Cr As on 08 December, 2022 | 08:47

What is the P/E ratio of Panacea Biotec ?

The P/E ratio of Panacea Biotec is 0.8 As on 08 December, 2022 | 08:47

What is the PB ratio of Panacea Biotec ?

The PB ratio of Panacea Biotec is 1 As on 08 December, 2022 | 08:47

Q2FY23